These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 23590713)

  • 1. Platelets and atherothrombosis: causes, targets and treatments for thrombosis.
    Siddiqui TI; Kumar K S A; Dikshit DK
    Curr Med Chem; 2013; 20(22):2779-97. PubMed ID: 23590713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet and von Willebrand factor interactions at the vessel wall.
    Ruggeri ZM; Ruggeri ZM
    Hamostaseologie; 2004 Feb; 24(1):1-11. PubMed ID: 15029268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet therapy and vascular disease: an update.
    Buch MH; Prendergast BD; Storey RF
    Ther Adv Cardiovasc Dis; 2010 Aug; 4(4):249-75. PubMed ID: 21303843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the platelet in the pathogenesis of atherothrombosis.
    Steinhubl SR; Moliterno DJ
    Am J Cardiovasc Drugs; 2005; 5(6):399-408. PubMed ID: 16259528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelets in atherothrombosis--diagnostic and prognostic value of platelet activation in patients with atherosclerotic diseases.
    Bigalke B; Schuster A; Sopova K; Wurster T; Stellos K
    Curr Vasc Pharmacol; 2012 Sep; 10(5):589-96. PubMed ID: 22338574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet drugs in cardiological practice: established strategies and new developments.
    Krötz F; Sohn HY; Klauss V
    Vasc Health Risk Manag; 2008; 4(3):637-45. PubMed ID: 18827913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelets in atherothrombosis.
    Vorchheimer DA; Becker R
    Mayo Clin Proc; 2006 Jan; 81(1):59-68. PubMed ID: 16438480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet function and antiplatelet therapy.
    Troxler M; Dickinson K; Homer-Vanniasinkam S
    Br J Surg; 2007 Jun; 94(6):674-82. PubMed ID: 17514662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanisms of platelet activation and development of antiplatelet agents].
    Cazenave JP; Gachet C; Lanza F
    Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1501-6. PubMed ID: 9092410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of platelets in atherothrombosis.
    Jennings LK
    Am J Cardiol; 2009 Feb; 103(3 Suppl):4A-10A. PubMed ID: 19166707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet interactions as therapeutic targets for prevention of atherothrombosis.
    Smid J; Braun-Dullaeus R; Gawaz M; Langer HF
    Future Cardiol; 2009 May; 5(3):285-96. PubMed ID: 19450054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From pathophysiology to targeted therapy for atherothrombosis: a role for the combination of statin and aspirin in secondary prevention.
    Chapman MJ
    Pharmacol Ther; 2007 Jan; 113(1):184-96. PubMed ID: 17070923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet effect of aspirin in patients with coronary artery disease.
    Grove EL
    Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-platelet Drug-loaded Targeted Technologies for the Effective Treatment of Atherothrombosis.
    Muruganantham S; Krishnaswami V; Alagarsamy S; Kandasamy R
    Curr Drug Targets; 2021; 22(4):399-419. PubMed ID: 33109044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protease-Activated Receptor 1 Inhibitors: Novel Antiplatelet Drugs in Prevention of Atherothrombosis.
    Al-Khafaji K; Mutyala M; Al-Khafaji N; Harper Y; Ismail I; Hakim H; Arora RR
    Am J Ther; 2017; 24(6):e730-e736. PubMed ID: 26398717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet proteomics: identification of potential therapeutic targets.
    Maguire PB
    Pathophysiol Haemost Thromb; 2003 Sep-2004 Dec; 33(5-6):481-6. PubMed ID: 15692264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of urinary 11-dehydro-thromboxane B
    Simeone P; Boccatonda A; Liani R; Santilli F
    Ageing Res Rev; 2018 Dec; 48():51-78. PubMed ID: 30273676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis.
    Jennings LK
    Thromb Haemost; 2009 Aug; 102(2):248-57. PubMed ID: 19652875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atherothrombosis and the management of the vulnerable vascular patient.
    Arora R; Rai F
    Am J Ther; 2009; 16(1):24-34. PubMed ID: 19114877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet receptors as therapeutic targets: Past, present and future.
    Jamasbi J; Ayabe K; Goto S; Nieswandt B; Peter K; Siess W
    Thromb Haemost; 2017 Jun; 117(7):1249-1257. PubMed ID: 28597906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.